Le plan d'homologation de Biosenic approuvé par le Tribual de l'Entreprise pour restructurer plus de 22 millions d'euros de dette et nomination de 2 administrateurs indépendants
An innovative drug to treat autoimmune diseases at the source of the immune cascade.
BioSenic offers a unique treatment value by developing two innovative product lines: an arsenic trioxide-based treatment for autoimmune diseases and cell therapy products.